TP53 and neoplasm: Furthermore, the tumor suppressors PTEN, TP53, DAB2, CDKN2A, PLAGL1, PEG3, RPS6KA2, NF1, BRCA1, BRCA2 and WWOX, all show ≥50% deletion among primary ovarian tumor samples.